Efficacy of anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation
EJHaem
.
2022 Sep 28;3(4):1442-1444.
doi: 10.1002/jha2.570.
eCollection 2022 Nov.
Authors
Alice Garnier
1
,
Amandine Le Bourgeois
1
,
Thierry Guillaume
1
2
,
Pierre Peterlin
1
,
Maxime Jullien
1
,
Marianne Coste-Burel
3
,
Marie C Béné
4
2
,
Patrice Chevallier
1
2
Affiliations
1
Department of Clinical Hematology CHU de Nantes Nantes France.
2
CNRS, INSERM, CRCI2NA Université de Nantes Nantes France.
3
Virology Nantes University Hospital Nantes France.
4
Hematology Biology CHU de Nantes Nantes France.
PMID:
36733664
PMCID:
PMC9885527
DOI:
10.1002/jha2.570
No abstract available
Keywords:
BNT162b2; COVID‐19; SARS‐CoV‐2 mRNA; allogeneic; aplastic anemia; third dose; vaccine.